These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16149589)

  • 1. [FGF23 (phosphatonin)].
    Fukumoto S
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():606-8. PubMed ID: 16149589
    [No Abstract]   [Full Text] [Related]  

  • 2. [Assay methods for FGF].
    Ito N; Fukumoto S
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():498-502. PubMed ID: 16279689
    [No Abstract]   [Full Text] [Related]  

  • 3. [FGF-23].
    Miyauchi A
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():378-84. PubMed ID: 15035156
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tumor-induced rickets/osteomalacia].
    Fukumoto S
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():523-8. PubMed ID: 16279694
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
    Jonsson KB; Zahradnik R; Larsson T; White KE; Sugimoto T; Imanishi Y; Yamamoto T; Hampson G; Koshiyama H; Ljunggren O; Oba K; Yang IM; Miyauchi A; Econs MJ; Lavigne J; Jüppner H
    N Engl J Med; 2003 Apr; 348(17):1656-63. PubMed ID: 12711740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGF23, hypophosphatemia, and rickets: has phosphatonin been found?
    Strewler GJ
    Proc Natl Acad Sci U S A; 2001 May; 98(11):5945-6. PubMed ID: 11371627
    [No Abstract]   [Full Text] [Related]  

  • 7. [Regulatory effect of FGF23 on phosphate and vitamin D metabolism].
    Yamashita T
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():519-22. PubMed ID: 16279693
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fibroblast growth factor 23, a new phosphaturic factor in hypophosphatemic rickets/osteomalacia].
    Nishizawa Y; Imanishi Y
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():469-74. PubMed ID: 16279684
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum FGF23 levels in normal and disordered phosphorus homeostasis.
    Weber TJ; Liu S; Indridason OS; Quarles LD
    J Bone Miner Res; 2003 Jul; 18(7):1227-34. PubMed ID: 12854832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement.
    Endo I; Fukumoto S; Ozono K; Namba N; Tanaka H; Inoue D; Minagawa M; Sugimoto T; Yamauchi M; Michigami T; Matsumoto T
    Bone; 2008 Jun; 42(6):1235-9. PubMed ID: 18396126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGF23 and disorders of phosphate homeostasis.
    Yu X; White KE
    Cytokine Growth Factor Rev; 2005 Apr; 16(2):221-32. PubMed ID: 15863037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic osteomalacia--a complex dance of factors.
    Carpenter TO
    N Engl J Med; 2003 Apr; 348(17):1705-8. PubMed ID: 12711747
    [No Abstract]   [Full Text] [Related]  

  • 13. [Urotensin II].
    Takahashi K; Totsune K; Murakami O
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():603-5. PubMed ID: 16149588
    [No Abstract]   [Full Text] [Related]  

  • 14. FGF23 is a putative marker for bone healing and regeneration.
    Goebel S; Lienau J; Rammoser U; Seefried L; Wintgens KF; Seufert J; Duda G; Jakob F; Ebert R
    J Orthop Res; 2009 Sep; 27(9):1141-6. PubMed ID: 19215029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [GLP-1 (glucagon-like peptide 1)].
    Matsuyama T; Komatsu R
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():496-8. PubMed ID: 16149560
    [No Abstract]   [Full Text] [Related]  

  • 16. Phosphaturic action of fibroblast growth factor 23 in Npt2 null mice.
    Tomoe Y; Segawa H; Shiozawa K; Kaneko I; Tominaga R; Hanabusa E; Aranami F; Furutani J; Kuwahara S; Tatsumi S; Matsumoto M; Ito M; Miyamoto K
    Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1341-50. PubMed ID: 20357029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor 23 and its receptors.
    Yu X; White KE
    Ther Apher Dial; 2005 Aug; 9(4):308-12. PubMed ID: 16076372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autosomal dominant hypophosphatemic rickets/osteomalacia].
    Tanaka H
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():529-33. PubMed ID: 16279695
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical usefulness of the determination of fibroblast growth factor 23 in the evaluation of patients with osteomalacia].
    Gifre L; Martínez de Osaba MJ; Monegal A; Guañabens N; Peris P
    Med Clin (Barc); 2014 May; 142(10):447-50. PubMed ID: 24629692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Androstanediol, androstanediol glucuronide].
    Kambegawa A
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():457-60. PubMed ID: 16149550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.